[Acute superior XXXX : a contrast study on short-and mid-term result between stent implantation and pharmaceutical thrombolysis].

@entity1 @entity63 @entity39 @entity384 @entity1397 @entity117 @entity1188 @entity432 @entity5327
OBJECTIVE: To compare the short-term and medium-term result of stent implantation with pharmaceutical thrombolysis in @entity1 with @entity432 . METHODS: From January, 2004 to December, 2008, thirty-five @entity1 diagnosed acute superior @entity5327 , 12 @entity1 treated with stent implantation (interventional therapy group) and 23 @entity1 with pharmaceutical thrombolysis (thrombolytic therapy group). Interventional therapy group treated with @entity384 and stent implantation assisted with anticoagulation, antiplatelet and @entity384 agents. Thrombolytic therapy group used urokinase combined with anticoagulation, antiplatelet and @entity384 agents. All @entity1 had taken @entity1397 and @entity117 orally after discharged and followed up. The clinical effects of both groups were evaluated separately and the Fisher exact test was used to analysis the significant differences. RESULTS: In the 23 cases of thrombolytic therapy group, 7 cases was effective, 16 cases was ineffective (7 cases aggravated or died, 9 cases turn to surgical operation). In the 12 cases of interventional therapy group, 10 cases treated with stent implantation (1 case died of acute @entity1188 3 days after interventional operation), 2 cases failed in recanalizing. All @entity1 were followed up after discharged (range 1 - 48 months, mean 15    12 months), 1 case in thrombolytic therapy group was stable, 6 cases died of the recurrence of @entity432 ; 7 cases in interventional therapy group was stable, 1 case died of acute @entity1188 20 months after interventional operation ( @entity63 not appeared), 1 case had @entity63 reoccurred and recovered by superior mesenteric artery thrombolysis. CONCLUSIONS: In the treatment of acute superior @entity5327 , stent implantation was obviously superior to pharmaceutical thrombolysis in improving @entity63 and survival, therefore it could provided a reliable choice for the @entity1 who had not appeared @entity39 .
